Efficacy and safety of insulin glargine 300 U/ml versus 100 U/ml in type 2 diabetic patients treated with basal insulin plus GLP-1 receptor agonist
Phase of Trial: Phase I
Latest Information Update: 24 Feb 2017
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Feb 2017 Status changed from recruiting to completed.
- 22 Mar 2016 Planned number of patients changed from 60 to 30.
- 20 Oct 2015 New trial record